1. Correction: The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease
- Author
-
Hsu, Yueh-Han, Yu, Hui-I, Chen, Hsuan-Ju, Li, Tsai-Chung, Hsu, Chih-Cheng, and Kao, Chia-Hung
- Subjects
Adult ,Aged, 80 and over ,Parathyroidectomy ,Multidisciplinary ,Adolescent ,lcsh:R ,Taiwan ,Correction ,lcsh:Medicine ,Middle Aged ,Peripheral Arterial Disease ,Young Adult ,Renal Dialysis ,Risk Factors ,Humans ,Kidney Failure, Chronic ,Hyperparathyroidism, Secondary ,lcsh:Q ,lcsh:Science ,Aged ,Follow-Up Studies ,Retrospective Studies - Abstract
The changes of the risk of peripheral arterial disease (PAD) in patients with end-stage renal disease after parathyroidectomy are scant.We used a nationwide health insurance claims database to select all dialysis-dependent patients with end-stage renal disease aged 18 years and older for the study population in 2000 to 2006. Of the patients with end-stage renal disease, we selected 947 patients who had undergone parathyroidectomy as the parathyroidectomy group and frequency matched 3746 patients with end-stage renal disease by sex, age, years since the disease diagnosis, and the year of index date as the non-parathyroidectomy group. We used a multivariate Cox proportional hazards regression analysis with the use of a robust sandwich covariance matrix estimate, accounting for the intra-cluster dependence of hospitals or clinics, to measure the risk of peripheral arterial disease for the parathyroidectomy group compared with the non-parathyroidectomy group after adjusting for sex, age, premium-based income, urbanization, and comorbidity.The mean post-op follow-up periods were 5.08 and 4.52 years for the parathyroidectomy and non-parathyroidectomy groups, respectively; the incidence density rate of PAD in the PTX group was 12.26 per 1000 person-years, significantly lower than the data in the non-PTX group (24.09 per 1000 person-years, adjusted HR = 0.66, 95% CI = 0.46-0.94).Parathyroidectomy is associated with reduced risk of peripheral arterial disease in patients with end-stage renal disease complicated with severe secondary hyperparathyroidism.
- Published
- 2016